Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
SEASONALE is an oral contraceptive containing levonorgestrel (progestin) and ethinyl estradiol (estrogen) in an extended-cycle formulation designed to reduce menstrual frequency. It prevents ovulation and thickens cervical mucus to provide contraceptive efficacy. The product is indicated for women seeking pregnancy prevention with fewer menstrual periods per year.
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting contracting brand team and shift toward lifecycle management and generic transition planning.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Working on SEASONALE offers exposure to mature product management and lifecycle strategy in the contraceptive space, with emphasis on competition management and generic transition planning. Career growth is limited by the product's LOE status; opportunities lie in market defense, cost optimization, and transition planning rather than expansion.
Worked on SEASONALE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.